M&A Deal Summary

The Harvard Drug Group Acquires Letco Med

On August 3, 2007, The Harvard Drug Group acquired medical products company Letco Med

Acquisition Highlights
  • This is The Harvard Drug Group’s 1st transaction in the Medical Products sector.
  • This is The Harvard Drug Group’s 1st transaction in the United States.
  • This is The Harvard Drug Group’s 1st transaction in Pennsylvania.
Investment Fate
  • Letco Med was divested to a consortium of strategic buyers in 2022 for 34M USD.

M&A Deal Summary

Date 2007-08-03
Target Letco Med
Sector Medical Products
Buyer(s) The Harvard Drug Group
Deal Type Add-on Acquisition

Target

Letco Med

Wayne, Pennsylvania, United States
Letco Med provides turnkey solutions for pharmacies worldwide, specializing in respiratory and compounded, customized medications, as well as technology-driven diagnostics. Letco Med offers a suite of pharmacy operations consulting, compounding chemicals, equipment and supplies, pre-mix medications, and industrial facilities equipment. Letco Med is based in Wayne, Pennsylvania.

Search 204,714 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

The Harvard Drug Group

Livonia, Michigan, United States

Category Company
Sector Distribution
DESCRIPTION

The Harvard Drug Group LLC is a pharmaceutical distributor in the United States. Harvard Drug supplies generic and branded pharmaceuticals to over 6,000 retail customers, which include independent, regional and national pharmacies.


DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 1 of 2
Year (2007) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-29 The Rugby Group

California, United States

Rugby OTC consists of more than 250 SKUs of cough and cold, allergy, pain relief, nausea relief, nicotine gum, vitamin and nutritional supplement products which are sold through various healthcare outlets across the United States.

Buy $117M